Keyphrases
Insulin
100%
Atrial Fibrillation
88%
Endothelial Function
86%
Type 2 Diabetic Patients
58%
Coronary Artery Disease
47%
Diabetes
43%
Serotonin
39%
Glucose Uptake
39%
Left Atrial Appendage
35%
Carvedilol
34%
Metoprolol
34%
Type 2 Diabetes Mellitus (T2DM)
34%
Tumor Necrosis Factor-α
34%
Gene Expression
34%
Forearm
31%
Obstructive Coronary Artery Disease
28%
Heart Failure
28%
Sodium Nitroprusside
25%
Patients with Heart Failure
25%
Endothelial Dysfunction
25%
Oxidative Stress
22%
Stable Angina
22%
Revascularization
22%
Risk of Death
21%
Denmark
21%
Insulin Resistance
21%
Non-invasive Test
20%
Postoperative Atrial Fibrillation
20%
Open Heart Surgery
19%
Hazard Ratio
18%
Cardiac Surgery
18%
Vasodilation
18%
Hypertension
18%
Angina
18%
Confidence Interval
17%
New-onset Atrial Fibrillation
17%
Metabolic Effects
17%
Function Genes
17%
Endothelial Progenitor Cells
17%
Care Delivery Model
17%
Ischemic Heart Disease
17%
P-wave
17%
Anticoagulants
17%
Fibrillation
17%
Statin Therapy
17%
Flow-mediated Dilation
17%
Hyperinsulinemia
17%
Recurring
17%
H2O2 Treatment
17%
Chronic Kidney Disease
17%
Medicine and Dentistry
Atrial Fibrillation
69%
Coronary Artery Disease
52%
Patient with Type 2 Diabetes
42%
Glucose Uptake
40%
Endothelial Function
35%
Tumor Necrosis Factor
34%
Gene Expression
34%
Maturity Onset Diabetes of the Young
34%
Diabetes
29%
Apoplexy
24%
Congestive Heart Failure
23%
Endothelial Dysfunction
23%
Vasodilatation
22%
Insulin Resistance
21%
Oxidative Stress
21%
Revascularization
20%
Serotonin
20%
Chronic Disease
20%
Skeletal Muscle
19%
Heart Surgery
19%
Stable Angina Pectoris
19%
Diagnosis
18%
Open Heart Surgery
18%
Coronary Angiography
18%
Acute Coronary Syndrome
18%
Threonine
17%
Antithrombotic
17%
Muscle Biopsy
17%
Fibrillation
17%
ST Elevation
17%
Cell Signaling Pathway
17%
Endothelial Nitric Oxide Synthase
17%
Chronic Kidney Disease
17%
Patient Participation
17%
Human Umbilical Vein Endothelial Cell
17%
P Wave
17%
Onset Age
17%
Brain Injury
17%
Hydrogen Peroxide
17%
Adiponectin
17%
Insulin Signaling
17%
Randomized Controlled Trial
17%
Amputation
17%
Hyperglycemia
15%
Pharmacology, Toxicology and Pharmaceutical Science
Atrial Fibrillation
51%
Serotonin
39%
Coronary Artery Disease
38%
Endothelial Dysfunction
37%
Nitric Oxide
36%
Warfarin
34%
Statin (Protein)
34%
Carvedilol
34%
Metoprolol
34%
Tumor Necrosis Factor
34%
Non Insulin Dependent Diabetes Mellitus
34%
Normal Human
34%
Nitroprusside Sodium
34%
Congestive Heart Failure
26%
Endothelial Nitric Oxide Synthase
20%
Anticoagulant Agent
19%
Stable Angina Pectoris
19%
Acute Coronary Syndrome
18%
Quinapril
17%
Chronic Kidney Failure
17%
Thromboembolism
17%
Etanercept
17%
Threonine
17%
Hydrogen Peroxide
17%
Hyperinsulinemia
17%
Randomized Controlled Trial
17%
Insulin Resistance
16%
Hyperglycemia
15%
